Factors Associated with Age-Related Maculopathy
与年龄相关性黄斑病相关的因素
基本信息
- 批准号:6873911
- 负责人:
- 金额:$ 16.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-01 至 2007-01-31
- 项目状态:已结题
- 来源:
- 关键词:age differenceatherosclerosiscardiovascular functionclinical researchcomputer data analysisdiabetes mellitusdietdisease /disorder etiologydisease /disorder proneness /riskdrug administration rate /durationgender differencehuman datahuman population studyhypertensioninflammationinformation retrievallipid metabolismlongitudinal human studymacular degenerationnervous system disorder epidemiologynutrient intake activityobesityracial /ethnic differencesmokingstatistics /biometrytobacco abuse
项目摘要
DESCRIPTION (provided by applicant): Despite intensive research, the precise etiology of age-related maculopathy (ARM) is poorly understood, and treatment options for this devastating eye disease are limited. Although some factors related to cerebrovascular or cardiovascular diseases, including smoking, alcohol and hypertension, also have been identified as risk factors for ARM, the interactions among these suspected risk factors with aging have not been fully investigated. Furthermore, since ARM is a complex disease, multifactors are likely to associate with its development. The Atherosclerosis Risk in Communities (ARIC) study was a population-based longitudinal study conducted between 1986 and 1999 in four U.S. communities to investigate the etiology and natural history of atherosclerosis. Retinal photographic images were obtained during the third visit (from 1993 to 1995) and graded. A high prevalence of ARM was observed in the population (5.6% in whites and 3.7% in blacks), providing a sufficient number of cases for risk factor analyses. Extensive individual-level information on potential risk factors is available in ARIC public domain data, including socioeconomic status, medication use, lifestyle factors, and quantitative measures of lipid, hematology, hemostasis and chemistry. We propose to employ a newly developed computer-based data mining technique to perform a secondary analysis on the data derived from ARIC, evaluating characteristics of approximately 600 ARM cases and 12,000 control individuals free from ARM at the time of retinal evaluation. Specific aims are 1) to explore the relationships between ARM and all the potential risk/protective factors for which data were collected in the ARIC study and 2) to investigate the interactions between the factors identified by aim 1 and aging in ARM. Our goal is to generate new hypotheses for further research on ARM.
描述(由申请人提供):尽管进行了深入的研究,但年龄相关性黄斑病变(ARM)的确切病因尚不清楚,并且这种毁灭性眼病的治疗方案有限。虽然一些与脑血管或心血管疾病相关的因素,包括吸烟、酒精和高血压,也被确定为ARM的危险因素,但这些可疑危险因素与衰老之间的相互作用尚未得到充分调查。此外,由于ARM是一种复杂的疾病,其发展可能与多种因素有关。社区动脉粥样硬化风险(ARIC)研究是一项基于人群的纵向研究,于1986年至1999年在美国四个社区进行,目的是调查动脉粥样硬化的病因学和自然史。在第三次访问期间(1993年至1995年)获得视网膜摄影图像并评分。在人群中观察到ARM的高患病率(白人5.6%,黑人3.7%),为风险因素分析提供了足够数量的病例。在ARIC的公共领域数据中,可以获得关于潜在危险因素的广泛的个人层面信息,包括社会经济地位、药物使用、生活方式因素以及脂质、血液学、止血和化学的定量测量。我们建议采用一种新开发的基于计算机的数据挖掘技术对来自ARIC的数据进行二次分析,评估大约600例ARM病例和12000名在视网膜评估时没有ARM的对照个体的特征。具体目的是:1)探索ARM与ARIC研究中收集数据的所有潜在风险/保护因素之间的关系;2)研究aim 1确定的因素与ARM中衰老之间的相互作用。我们的目标是为ARM的进一步研究产生新的假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HONG LAI其他文献
HONG LAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HONG LAI', 18)}}的其他基金
Factors Associated with Age-Related Maculopathy
与年龄相关性黄斑病相关的因素
- 批准号:
7012257 - 财政年份:2005
- 资助金额:
$ 16.24万 - 项目类别:
相似国自然基金
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
- 批准号:91957111
- 批准年份:2019
- 资助金额:80.0 万元
- 项目类别:重大研究计划
高尿酸血症促进动脉粥样硬化机制探讨
- 批准号:81170251
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
- 批准号:81070247
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
- 批准号:81000086
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
- 批准号:30971216
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
- 批准号:30871040
- 批准年份:2008
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 16.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
- 批准号:
10750690 - 财政年份:2024
- 资助金额:
$ 16.24万 - 项目类别:
Colchicine for the prevention of vascular events after an acute intracerebral hemorrhage (CoVasc-ICH)
秋水仙碱用于预防急性脑出血后血管事件(CoVasc-ICH)
- 批准号:
485530 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Operating Grants
Identifying the Role of Sex Hormones in Carotid Atherosclerotic Plaque Instability
确定性激素在颈动脉粥样硬化斑块不稳定中的作用
- 批准号:
494557 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Operating Grants
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Regulation of Vascular Calcification by Adventitial Endothelial Cells
外膜内皮细胞对血管钙化的调节
- 批准号:
10642619 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Advancing Student Potential for Inclusion with Research Experiences (ASPIRE)
通过研究经验提升学生融入的潜力(ASPIRE)
- 批准号:
10678356 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:














{{item.name}}会员




